Trials / Completed
CompletedNCT05517538
Split-face Study: Cosmetic Botulinum Toxin Type A Injection Under Electromyography-guidance Versus Conventional Palpation Technique
COMPARISON BETWEEN THE EFFICACY AND DURATION OF COSMETIC BOTULINUM TOXIN TYPE A INJECTION WITH AND WITHOUT ELECTROMYOGRAPHIC GUIDANCE
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Mohamed Hayder Oleish Salih · Academic / Other
- Sex
- All
- Age
- 25 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study was to compare between the conventional palpation method of botulinum toxin type A injection and the electromyography-guided method using clinical parameters and electromyography analysis.
Detailed description
The study was conducted on 15 healthy-looking female subjects with visible glabellar rhytids when frowning. All participants were recruited from the outpatient clinic of Dermatology Department, Main University Hospital, Faculty of Medicine, Alexandria University. The mean age was 46.27 ± 6.31 with a range from 33 to 59 years. All 15 subjects completed the study. Each subject provided a right and left corrugator supercilii muscles to the study. Each muscle was divided into a body and a tail, each part injected separately (n=60). Neurotoxin injection into the corrugator body and tail by palpation method on one side and under EMG-guidance on the other. Photographs were taken both at rest, and while frowning at each visit: pre-operatively, after 2 weeks and after 3 months. Clinical grading according to static and dynamic Merz glabellar frown line scales and EMG analysis was done at each visit: pre-operatively, after 2 weeks and after 3 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Electromyography-Needle Intramuscular Drug guidance | EMG-guided needle neurotoxin injection |
| DRUG | Botulinum toxin type A | Botulinum toxin type A injection into the Corrugator Supercilii muscle |
Timeline
- Start date
- 2021-08-09
- Primary completion
- 2021-12-02
- Completion
- 2021-12-15
- First posted
- 2022-08-26
- Last updated
- 2022-08-26
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05517538. Inclusion in this directory is not an endorsement.